FDA Class I drug recalls

This page indexes the U.S. FDA drug recalls that the agency has classified as Class I. It is a regulatory finding aid, not medical advice.

What "Class I" means as a regulatory classification

Class I is the most serious of the three classifications the FDA uses when it records a drug recall in its enforcement reports. The classification is the agency's own categorisation of the recall event within its regulatory framework. It is assigned by the FDA, captured as a field in the enforcement report, and reproduced here exactly as the source states it. On this site the label carries no meaning beyond that administrative one: it is not a personalised risk score, not a clinical judgement, and not a statement about how any individual should act.

Because Class I is the agency's highest-priority recall category, these records are often the ones that regulatory-affairs and quality-assurance teams want to locate first when they scan the enforcement reporting stream. Distributors and procurement teams may track Class I actions to understand which marketed products have been the subject of the agency's most serious recall tier over a given window. The value of indexing them here is simply speed of retrieval and ease of dating and cross-referencing — every entry links straight back to the verifiable openFDA source so the official record can be confirmed.

How to read the Class I list

The table below lists the Class I recall records currently in the indexed dataset, newest first by report date. Each row links to a dedicated record page that lays out the product description, the recalling firm, the firm's stated reason for the recall, the distribution pattern, the geographic fields, and the relevant dates — all as regulatory data points drawn from the enforcement report. From each record page you can follow a link to the official openFDA query that returns the source report.

Two cautions are worth repeating. First, the presence of a product in this list reflects a regulatory action recorded by the FDA; it is an administrative fact and not a verdict on a company or a clinical warning to any person. Second, the list reflects what had been ingested at the most recent pipeline run, which can lag the live FDA record. For any decision, confirm the current status against the official source.

RecordTypeDate
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.Ongoing2026-05-27
Lactated Ringer's Injection USP, 1000 mL container, Rx only, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7750-07.Ongoing2026-05-13
Magnesium Sulfate in Water for Injection, 4g/100 mL (40mg/mL) IV bag, further packaged in cartons of 12 x 100 mL IV bags, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad, 382110, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1720-3.Ongoing2026-04-08
Webcol Alcohol Prep pad (70% isopropyl alcohol) 2 ply, 200 count boxes, Cardinal Health 200 LLC 3651 Birchwood Drive, Waukegan, IL 60085.Ongoing2026-03-25
Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0Ongoing2026-03-11
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7Ongoing2026-03-11
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, ChinaOngoing2026-03-11
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617, NDC 69448-025-63Ongoing2026-02-18
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San Miguel Drive, Suite #296, Newport Beach, CA 92660Ongoing2026-02-11

What each Class I record contains

Every Class I record page on this site lays out the same regulatory fields, drawn directly from the FDA enforcement report. The recall number and event identifier let you tie the entry back to the agency's own systems and to other recall lines that share the same event. The product description records the item as the firm characterised it. The recalling firm is the company that initiated or conducted the action. The firm's stated reason is reproduced verbatim as a data field — it explains, in the firm's words, why the recall was undertaken, and it is presented for identification only rather than as any kind of instruction. The distribution pattern describes how widely the product was distributed, and the state and country fields locate the firm. Finally, a set of dates — report date, recall initiation date and, where applicable, termination date — lets you place the action precisely in time.

Presenting these fields consistently is what turns a stream of individual enforcement reports into something you can scan, sort and compare. But the consistency is purely structural: it organises the regulator's data without adding interpretation. Nothing on a Class I record page assesses risk to any individual, recommends a course of action, or makes a clinical claim. The classification itself is the FDA's, the field values are the FDA's, and the role of this page is only to surface them clearly and link you straight back to the authoritative source.

Related recall views

Class I recalls are one of three regulatory tiers. You can also review Class II recalls and Class III recalls, or return to the drug recalls hub for the full explanation of how recall classifications and statuses are defined. To understand the terminology used across these pages, see the regulatory intelligence glossary, and for the data lineage see the methodology and FDA data sources pages.

Source & provenance

Official source
https://open.fda.gov/apis/drug/enforcement/
Source dataset
openFDA Drug Enforcement API
Publication date
Not available
Ingested
2026-06-09

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.